Regioselective synthesis of novel N2- and N4- substituted 7-methylpyrazolo[4,5-e][1,2,4]thiadiazines

Molecules

Volumn 11, Issue 11, 2006, Pages 827-836

  Liu, Xinyong ^a   Yan, Renzhang ^a   Chen, Niangen ^a   Xu, Wenfang ^a   Molina, Maria Teresa ^b   Vega, Salvador ^b  

^a SHANDONG UNIVERSITY   (China)

^b INSTITUTO DE QUÍMICA MÉDICA   (Spain)

Author keywords

Alkylation; One pot reaction; Pyrazolothiadiazines; Regioselectivity; Synthesis

Indexed keywords

PYRAZOLE DERIVATIVE; THIADIAZINE DERIVATIVE;

ALKYLATION; ARTICLE; CHEMISTRY; STEREOISOMERISM; SYNTHESIS;

ALKYLATION; PYRAZOLES; STEREOISOMERISM; THIADIAZINES;

EID: 33845423666     PISSN: 14203049     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/11110827     Document Type: Article

References (10)

1. Robertson, D. W.; Steinberg, M. I. Potassium channel modulators: scientific applications and therapeutic promise. J. Med. Chem. 1990, 33, 1529-1541.
2. Longman, S. D; Hamilton, T. C. Potassium channel activator drugs: mechanisium of action, pharmacological properties, and therapeutical potential. Med. Res. Rev. 1992, 12, 73-148.
3. Pirotte, B.; De Tullio, P.; Lebrun, P.; Antoine, M.H.; Fontaine, J.; Masereel, B.; Schynts, M.; Dupont, L.; Herchuelz, A., Delarge, J. 3-(Alkylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as powerful inhibitors of insulin release from rat pancreatic B-cells: a new class of potassium channel openers? J. Med. Chem. 1993, 36, 3211-3213.
4. Pirotte, B.; Podona, T.; Diouf, O.; de Tullio, P.; Lebrun, P.; Dupont, L.; Somers, F.; Delarge, J.; Morain, P.; Lestage, P.; Lepagnol, J.; Spedding, M. 4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2,4- pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5- methylisoxazol-4-yl)propionic acid receptors: design, synthesis, pharmacology, and structure-activity relationships. J. Med. Chem. 1998, 41, 2946-2959.
5. Martinez, A.; Esteban, A. I.; Herrero, A.; Ochoa, C.; Andrei, G.; Snoeck, R.; Balzarini, J.; De Clercg, E. Imidazothiadiazine dioxides: synthesis and antiviral activity. Bioorg. Med. Chem. 1999, 7, 1617-1623.
6. Holla, B. S.; Sarojini, B. K.; Rao, B. S.; Akberali, P. M.; Kumari, N. S.; Shetty, V. Synthesis of some halogen-containing 1,2,4-triazolo-1,3,4- thiadiazines and their antibacterial and anticancer screening studies. Part I. Farmaco. 2001, 56, 565-570.
7. Arranz, M.E.; Vega, S.; Diaz, J. A. Synthesis of hetero[1,2,4]thidiazine 1,1-dioxides Heterocycles 1997, 45, 1767-1774.
8. Arranz, E.; Dia, J.A.; Ingate, S. T.; Witvrouw, M.; Pannecouque, C.; Balzarini, J.; De Clercq, E.; Vega, S. Novel 1,1,3-trioxo-2H,4H-thieno[3,4-e][1, 2,4]thiadiazine derivatives as non-nucleoside reverse transcriptase inhibitors that inhibit human immunodeficiency virus type 1 replication. J. Med. Chem. 1998, 41, 4109-4017.
9. Witvrouw, M.; Arranz, M. E; Pannecouque, C.; Declercq, R.; Jonckheere, H.; Schmit, J.C.; Vandamme, A. M.; Dia, J.A.; Ingate, S.T.; Desmyter, J.; Esnouf, R.; Meervelt, L.V.; Vega, S.; Balzarni, J.; De Clercq, E. 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazines (TTDs) derivatives: a non-nucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activity. Antimicrob. Agents Chemother. 1998, 42, 618-623.
10. George, A.P.; Edmond, J. LV. Bioisosterism: a rational approach in drug design. Chem. Rev. 1996, 96, 3147-3176.